Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.

Yunpeng ZhuWei ZhangArnaldo DimagliLin HanZhaoyun ChengJu MeiXin ChenXiaowei WangYanzai ZhouQing XueJunlong HuMin TangRui WangYuanyuan SongLei KangBjorn RedforsMario F L Gaudino Qiang Zhao

Published in: BMJ (Clinical research ed.) (2024)

NCT03987373ClinicalTrials.gov NCT03987373.

Keyphrases

coronary artery bypass
antiplatelet therapy
percutaneous coronary intervention
clinical trial
study protocol
acute coronary syndrome
open label
phase iii
phase ii
coronary artery disease
double blind
placebo controlled
randomized controlled trial
atrial fibrillation